As far as neuroblastoma therapy is concerned, several clinical trials have demonstrated retinoid effectiveness when used in combination with IFN–alpha [8] or intensive chemoradiotherapy, which significantly improved event–free survival in high–risk neuroblastoma [9]. The gene discussed is IFNA1; the disease is neuroblastoma.